TrialInternational journal of urology : official journal of the Japanese Urological Association2019

Long-term safety and efficacy of antimuscarinic add-on therapy in patients with overactive bladder who had a suboptimal response to mirabegron monotherapy: A multicenter, randomized study in Japan (MILAI II study).

Osamu Yamaguchi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.